|
Market Closed -
NYSE
16:00:02 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 71.79 USD | +0.06% |
|
+5.48% | +21.31% |
| 08-18 | Ingevity Insider Sold Shares Worth $764,673, According to a Recent SEC Filing | MT |
| 07-30 | Ingevity Corporation, Q2 2026 Earnings Call, Jul 30, 2026 |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
 | 1.29B | -12.96% | 22.58% | - | - | 2.84x | |
| 16.19B | 18.43% | 24.68% | 10.4% | 12.54% | -1.62x | |
| 70.04B | 2.71% | 4.84% | 5.81% | 2.55% | 2.8x | |
| 1.56B | 16.77% | 21.4% | 23.79% | 16.63% | -1.08x | |
| 19.34B | 5.16% | 7.52% | 8% | 5.65% | 1.61x | |
| 23.29B | 0.32% | 0.81% | 0.7% | 0.2% | 4.53x | |
| 17.81B | 1.74% | 4.77% | 5.85% | 2.37% | 1.96x | |
| 7.21B | -1.01% | 10.94% | 5.61% | 3.19% | 1.67x | |
| 16.6B | 4.46% | 15.81% | 15.54% | 6.78% | 1.12x | |
| 1.68B | 11.62% | 16.2% | 14.27% | 8.33% | 1.12x | |
| 1.76B | 17.78% | 22.73% | 20.3% | 19.22% | 0.03x | |
| 5.94B | 3.27% | 8.44% | 5.85% | 2.63% | 2.92x | |
| 14.64B | 2.62% | 8.95% | 6.4% | 3.39% | 2.86x | |
| 1.35B | 2.26% | 2.29% | 2.53% | - | - | |
| 6.41B | 4.08% | 9.37% | 5% | 7.8% | 0.34x | |
| 1.82B | -46.33% | 11.35% | 6.58% | 3.06% | 2.92x | |
| 5B | 0.7% | 13.16% | 23.89% | 4.62% | 1.81x | |
| 3.23B | 6.58% | 11.78% | 12.72% | - | 0.96x | |
| Average | 11.95B | 2.12% | 12.09% | 10.19% | 6.6% | 1.58x | |
| Weighted average by Cap. | 24.57B | 8.15% | 13.97% | 9.67% | 7.78% | 0.85x |
- Stock Market
- Stocks
- NGVT Stock
- Sector Ingevity Corporation
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
